These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 30842140

  • 1. Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Spartalis E, Athanasiadis DI, Chrysikos D, Spartalis M, Boutzios G, Schizas D, Garmpis N, Damaskos C, Paschou SA, Ioannidis A, Tsourouflis G, Dimitroulis D, Nikiteas NI.
    Anticancer Res; 2019 Mar; 39(3):1119-1127. PubMed ID: 30842140
    [Abstract] [Full Text] [Related]

  • 2. Histone Deacetylase Inhibitors and Papillary Thyroid Cancer.
    Spartalis E, Kotrotsios K, Chrysikos D, Spartalis M, Paschou SA, Schizas D, Tsamakis K, Dimitroulis D, Troupis T, Nikiteas N.
    Curr Pharm Des; 2021 Mar; 27(18):2199-2208. PubMed ID: 33308111
    [Abstract] [Full Text] [Related]

  • 3. Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Damaskos C, Garmpis N, Valsami S, Spartalis E, Antoniou EA, Tomos P, Karamaroudis S, Zoumpou T, Pergialiotis V, Stergios K, Michaelides C, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D.
    Anticancer Res; 2016 Oct; 36(10):5019-5024. PubMed ID: 27798860
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer.
    Kim SM, Park KC, Jeon JY, Kim BW, Kim HK, Chang HJ, Choi SH, Park CS, Chang HS.
    BMC Cancer; 2015 Dec 23; 15():1003. PubMed ID: 26698299
    [Abstract] [Full Text] [Related]

  • 6. Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    J Clin Endocrinol Metab; 2015 Feb 23; 100(2):E253-61. PubMed ID: 25389633
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.
    Catalano MG, Pugliese M, Gargantini E, Grange C, Bussolati B, Asioli S, Bosco O, Poli R, Compagnone A, Bandino A, Mainini F, Fortunati N, Boccuzzi G.
    Int J Cancer; 2012 Feb 01; 130(3):694-704. PubMed ID: 21400508
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
    Lin SF, Lin JD, Chou TC, Huang YY, Wong RJ.
    PLoS One; 2013 Feb 01; 8(10):e77684. PubMed ID: 24155971
    [Abstract] [Full Text] [Related]

  • 10. Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models.
    Yun HJ, Kim HJ, Kim J, Kim SY, Chang HS, Park CS, Chang HJ, Park KC.
    Int J Mol Sci; 2021 Jan 07; 22(2):. PubMed ID: 33430361
    [Abstract] [Full Text] [Related]

  • 11. Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations?
    Garmpis N, Damaskos C, Garmpi A, Dimitroulis D, Spartalis E, Margonis GA, Schizas D, Deskou I, Doula C, Magkouti E, Andreatos N, Antoniou EA, Nonni A, Kontzoglou K, Mantas D.
    Anticancer Res; 2017 Oct 07; 37(10):5355-5362. PubMed ID: 28982843
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitors in the treatment of lymphoma.
    Lemoine M, Younes A.
    Discov Med; 2010 Nov 07; 10(54):462-70. PubMed ID: 21122478
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
    Pugliese M, Fortunati N, Germano A, Asioli S, Marano F, Palestini N, Frairia R, Boccuzzi G, Catalano MG.
    Thyroid; 2013 Jul 07; 23(7):838-46. PubMed ID: 23531031
    [Abstract] [Full Text] [Related]

  • 14. Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents.
    Cappellacci L, Perinelli DR, Maggi F, Grifantini M, Petrelli R.
    Curr Med Chem; 2020 Jul 07; 27(15):2449-2493. PubMed ID: 30332940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.
    Jang S, Yu XM, Odorico S, Clark M, Jaskula-Sztul R, Schienebeck CM, Kupcho KR, Harrison AD, Winston-McPherson GN, Tang W, Chen H.
    Cancer Gene Ther; 2015 Aug 07; 22(8):410-6. PubMed ID: 26251030
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.